Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Research & Development (2010 - 2026)

Vericel (VCEL) posted Research & Development of $7.5 million for Q2 2026, down 7.54% sequentially from $8.1 million in Q1 2026, and up 11.32% YoY from $6.7 million in Q2 2025.

Analysis

Vericel (VCEL) Research & Development (2010 - 2026) Analysis & Trends

Vericel has reported Research & Development for 17 years, with the latest figure at $7.5 million in Q2 2026.

  • Quarterly Research & Development rose 11.32% year-over-year to $7.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.2 million (up 16.63% YoY) and the FY2025 annual result came in at $27.6 million, up 11.15% from the prior year.
  • Research & Development fell to $7.5 million in Q2 2026 per VCEL's latest filing, from $8.1 million in the prior quarter.
  • Over five years, Research & Development peaked at $8.1 million in Q1 2026 and troughed at $4.8 million in Q2 2022.
  • A 5-year average of $6.1 million and a median of $5.9 million in 2023 frame the typical range for Research & Development.
  • The widest YoY moves for Research & Development: up 47.33% in 2025, down 8.58% in 2025.
  • Over 5 years, Research & Development stood at $5.2 million in 2022, then retreated by 6.56% to $4.9 million in 2023, then advanced by 0.45% to $4.9 million in 2024, then soared by 47.33% to $7.3 million in 2025, then climbed by 3.31% to $7.5 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $7.5 million, $8.1 million, and $7.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -486.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 651.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 394.92 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 612.28 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 413.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 97.90 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 210.03 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 7.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.49 Mn
Mar 31, 2026 8.10 Mn
Dec 31, 2025 7.25 Mn
Sep 30, 2025 6.32 Mn
Jun 30, 2025 6.73 Mn
Mar 31, 2025 7.26 Mn
Dec 31, 2024 4.92 Mn
Sep 30, 2024 6.09 Mn
Jun 30, 2024 7.36 Mn
Mar 31, 2024 6.42 Mn
Dec 31, 2023 4.90 Mn
Sep 30, 2023 5.68 Mn
Jun 30, 2023 5.25 Mn
Mar 31, 2023 5.21 Mn
Dec 31, 2022 5.25 Mn
Sep 30, 2022 5.05 Mn
Jun 30, 2022 4.79 Mn
Mar 31, 2022 4.86 Mn
Dec 31, 2021 3.92 Mn
Sep 30, 2021 4.28 Mn